Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:53:29 EDT Sat 24 Oct 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 39 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-10-24 16:06U:GGIINews ReleaseSiren's Tale Vodka to Exhibit at SoCal Cocktail and Spirits Fest
2026-10-24 15:19U:TECKNews ReleaseTeck Provides Update on Highland Valley Copper Operations
2026-10-24 13:00U:AXONNews ReleaseAxon Announces Body 5: Next-Generation Camera Built for the AI Era
2026-10-24 11:18U:PFENews ReleasePfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
2026-10-24 10:35U:AZNNews ReleaseIMFINZI(TM) (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
2026-10-24 10:30U:AZNNews ReleasePerioperative IMFINZI(TM) (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
2026-10-24 10:30U:AMGNNews ReleaseIMDELLTRA(TM) IN COMBINATION WITH IMFINZI(TM) REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
2026-10-24 08:45U:PBLSNews ReleaseParabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
2026-10-24 08:00U:SMTCNews ReleaseSemtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026
2026-10-24 08:00U:BAYZFNews ReleaseESMO 2026: NUBEQA(TM) (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence
2026-10-24 08:00U:BAYRYNews ReleaseESMO 2026: NUBEQA(TM) (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence
2026-10-24 07:01U:INCYNews ReleaseGenmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
2026-10-24 07:01U:GMABNews ReleaseGenmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
2026-10-24 07:00U:NBTXNews ReleaseNANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
2026-10-24 07:00U:INCYNews ReleaseIncyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
2026-10-24 05:30U:JNJNews ReleaseJohnson & Johnson announces ERLEADA(TM) (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
2026-10-24 04:15U:ONCNews ReleaseBeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
2026-10-24 04:15U:CMPXNews ReleaseCompass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026
2026-10-24 04:15U:CELCNews ReleaseCelcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
2026-10-24 02:30U:ZYMENews ReleaseZymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
2026-10-24 02:30U:LLYNews ReleaseLilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRalpha-targeting ADC at ESMO 2026
2026-10-24 02:30U:IMTXNews ReleaseImmatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
2026-10-24 00:00U:LAWRNews ReleaseRobot Consulting Announces Receipt of Nasdaq Delisting Determination and Request to Appeal such Determination Before a Hearings Panel
2026-10-23 20:36U:DNRSFNews ReleaseDENARIUS METALS FILES TORAL PROJECT TECHNICAL REPORT ON SEDAR+
2026-10-23 20:36U:DNRSFNews ReleaseDENARIUS METALS FILES TORAL PROJECT TECHNICAL REPORT ON SEDAR+
2026-10-23 20:00U:RXSTNews ReleaseRxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
2026-10-23 19:59U:USMTNews ReleaseUS Metro Bancorp Announces Third Quarter 2026 Results
2026-10-23 19:20U:TVTXNews ReleaseTravere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI(TM) (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
2026-10-23 19:16U:HENews ReleaseHawaiian Electric Industries to Announce Third Quarter 2026 Results November 6
2026-10-23 19:08U:TZOONews ReleaseClub Offers for Travel Enthusiasts in Canada
2026-10-23 19:01U:SHVLFNews ReleaseStarcore Announces Results of Annual General Meeting
2026-10-23 19:00U:HIDDFNews ReleaseHYDAWAY DIGITAL ANNOUNCES PROPOSED SHARE CONSOLIDATION AND NAME CHANGE
2026-10-23 18:49U:MRZLFNews ReleaseMirasol Resources Announces Option Grants
2026-10-23 18:45U:PGZNews ReleasePrincipal Real Estate Income Fund Announces Changes in Portfolio Management
2026-10-23 18:30U:BGTTFNews ReleaseGOAT Industries Signs Definitive Agreement To Acquire Epoxy AI Customer Contract Revenues
2026-10-23 18:25U:CWLPFNews ReleaseCaldwell Announces Sale of IQTalent
2026-10-23 18:17U:BRCBNews ReleaseBlack Rock Coffee Bar Continues Expansion in California with New Rancho Cucamonga Location
2026-10-23 18:00U:UUUFFNews ReleaseUranium One Mining Corp. Engages Adrian Huerta Ruiz as Technical Advisor for Athabasca Basin Uranium Exploration
2026-10-23 18:00U:CEXYFNews ReleaseCopper One Commences Up to 10,000 Foot Phase 2 Drill Program at Flagship Majuba Hill Copper-Silver-Gold Project, Nevada